HMGB1 and cervical squamous cell carcinoma: Meanwhile, Chung et al [23] and Sheng et al [31] respectively exhibited serum HMGB1 was a remarkable biomarker to predict pancreatic ductal adenocarcinoma and recurrent cervical squamous cell carcinomas with superior sensitivity or specificity compared to existing biomarkers.